Genetics of β-amyloid precursor protein in alzheimer’s disease

Julia, T.C.W.Email Author, Goate, A.M.: 2017 Cold Spring Harbor Perspectives in Medicine Volume 7, Issue 6, Article number a024539 Read More


Alzheimer’s disease (AD) is characterized neuropathologically by neuronal cell loss, extracellular neuritic plaques composed of β-amyloid (Aβ), and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein. Aβ is generated by proteolytic processing of the β-amyloid precursor protein (APP). Most individuals with Down syndrome (DS) have three copies of APP, leading to elevated APP expression, increased Aβ deposition, and characteristic AD neuropathology. Sequencing of APP in familial early-onset AD iden-tified missense mutations that cause AD, while a recently discovered coding variant, APP A673T, reduces the risk for AD. Cellular and animal studies show that risk-associated muta-tions increase total Aβ levels, Aβ42 levels, or Aβ fibrillogenesis, while protective alleles reduce Aβ levels. Together, these studies provide compelling evidence for the Aβ hypothesis and suggest that therapeutics that reduces Aβ levels or Aβ fibrillogenesis should lower the risk for or prevent AD. © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

 Full Text


Posted on June 26, 2017
Posted in: Neurogenetics, Publications Authors: